I'll research JPMorgan ahead of tomorrow's earnings. Let me gather recent filings, transcripts, news, and price action.Let me read the Q1 2026 earnings materials and gather sector/macro context.Let me pull the guidance details from the Q1 2026 call and check analyst estimates/consensus.I have what I need. Let me quickly compute a couple of price stats to ground the setup.Here is my earnings preview.
JPMorgan enters this print as the best-positioned name in the group but also the most fully-valued going in. Q1 was a blowout (record markets, +28% IB fees, 23% ROTCE), buy-side "whisper" numbers reportedly sit above the Street, and the stock is only ~1% off its recent high. That combination — high internal bar plus a "good news is priced in" tape — is the central tension for the reaction.
| Metric | Q2'26 Consensus | Y/Y |
|---|---|---|
| EPS | ~$5.61 | +13% (vs ~$4.96) |
| Revenue | ~$49.5B | — |
| Net interest income | ~$25.6B | +9.8% |
| Non-interest income | ~$23.7B | +5.9% |
| Markets/trading | >$10B | ~+15% |
Bogeys worth remembering from Q1'26 (the beat-and-raise base): EPS $5.94, net income $16.5B, managed revenue $50.5B, record Markets revenue $11.6B (FICC +21%, Equities +17%), IB fees +28%, and CET1 of 14.3%. Note the whisper-vs-consensus gap — a UBS analyst has flagged risk that mega-cap bank day is "a bit of a mess" because expectations across the group are so elevated.
1) Capital markets — the swing factor. This is where the beat (or disappointment) lives. The Street models trading north of $10B (~+15% y/y) and IB fees up mid-teens, with the IPO revival and geopolitical/rate volatility as tailwinds. Management on the Q1 call described the IB pipeline as "resilient, maybe surprisingly resilient." Watch two things: (a) whether the record Q1 markets run-rate held into Q2, and (b) M&A/ECM commentary — some of Q1's strength came from accelerated deal closings (faster regulatory approvals), which can pull revenue forward.
2) NII trajectory & the rate regime flip. Full-year guidance stands at ~$103B total NII / ~$95B NII ex-Markets, with adjusted expenses ~$105B. The key change since April: the rate narrative has flipped from cuts to potential hikes. New Fed Chair Warsh is weighing whether to undo last year's cuts amid sticky inflation and a renewed Middle East energy spike, with markets pricing meaningful odds of hikes by December. JPM is asset-sensitive (EAR ~$1.8B), so higher-for-longer is a modest tailwind — but note management said the full-year average impact of removing cuts was only ~20bps, so don't expect a huge NII raise from rates alone. A guidance bump on NII and/or expenses is very much in play (Dimon explicitly said $105B "is not a promise, it's an outcome" — expenses will run higher if markets stay hot, which is a good problem).
3) Credit & the consumer. Card net charge-off guidance is ~3.4%; Q1 card NCO printed 3.47%. Management continues to call the consumer "resilient," helped by a strong labor market (and, in Q1, tax refunds). The tell to watch is the reserve build: in Q1 they consciously chose not to add downside skew despite Middle East risk, leaning on existing conservatism. With energy prices spiking again on renewed conflict, any change to scenario weightings or a chunkier build would signal caution. Also watch wholesale credit for idiosyncratic downgrades.
4) Capital return & regulation. JPM ran ~$8.1B of net buybacks + $4.1B dividend in Q1, with ~$40B of excess capital and CET1 at 14.3%. Two regulatory threads matter: management is broadly relieved the Basel III/G-SIB re-proposals softened the worst of 2023, but is still vocally fighting the G-SIB surcharge (they flagged a path to 5.2% by 2028 and ~$20B of incremental G-SIB capital), which specifically penalizes the low-density Markets balance-sheet growth. Expect updated capital-return appetite and possibly a dividend action given the recent stress-test/CCAR cycle.
| Bullish if… | Bearish if… |
|---|---|
| Markets/IB beat the >$10B bar; pipeline commentary strong | Trading merely "in line" — priced in, sell-the-news |
| NII and/or expense guide raised (good-problem spend) | Reserve build jumps / consumer cracks appear |
| Constructive capital-return + dividend action | Cautious macro tone from Dimon; recession/credit-cycle warnings |
| Clean, contained succession/regulatory commentary | Succession or G-SIB overhang dominates the narrative |
Bottom line: Fundamentally JPM looks set up to beat again, led by capital markets, with a real chance of an NII/expense guidance raise given the shift to a higher-for-longer (possibly hiking) rate backdrop. The risk is entirely about expectations: with whisper numbers above consensus and the stock near highs, a "solid but in-line" trading number could still get sold. Watch the guidance revisions, the reserve decision, and Dimon's macro/succession tone more than the headline EPS.
Note: figures reflect consensus estimates and prior-quarter results gathered from filings, transcripts, and news ahead of the report; actuals will be released with the Q2 earnings materials on July 14.